Research shows that a newly-developed wireless EKG patch is as accurate, if not more accurate, than results from traditional EKG machines. The device is known as the EKG Patch Solution.

The 100 and 400 mg doses had the most beneficial tendency for early recovery after an average of eight days, and the 25 mg dose after nine days. Patients in the standard-of-care control group achieved ...

Worldwide, over 300 million electrocardiograms (EKGs) are performed each year, with one-third of those taking place in the ...

The device, known as the EKG Patch Solution, was developed by the Cincinnati-based MG Medical Products. Study findings were ...

CVS Health Corp. faces continued challenges in its insurance business, prompting the company to shake up its management ranks in a bid to get back on track. Shares of the pharmacy and healthcare ...

Obe-cel was designed to increase T-cell persistence and reduce T-cell exhaustion and was shown to improve response rates and survival, particularly in patients with low leukemia burden.